The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition

R. Kisilevsky, M. D. Benson, M. A. Axelrad, L. Boudreau

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Animals treated with AgNO3 and amyloid-enhancing factor deposit large quantities of splenic amyloid in 48 hours. The kinetics of SAA production were examined in such a model in the presence and absence of an inhibitor of liver protein synthesis (ethionine). Ethionine had little effect on splenic protein synthesis but inhibited both the production of SAA and liver protein synthesis. When experiments were performed with fed mice, ethionine induced an inhibition of liver protein synthesis lasting 16 hours. Thereafter, liver protein synthesis began to recover, accompanied by a rise in plasma SAA levels. These results are consistent with hepatic but not splenic synthesis of SAA.

Original languageEnglish (US)
Pages (from-to)206-210
Number of pages5
JournalLaboratory Investigation
Volume41
Issue number3
StatePublished - Jan 1 1979
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition'. Together they form a unique fingerprint.

  • Cite this